<DOC>
	<DOC>NCT02666612</DOC>
	<brief_summary>Monitoring of circulating endothelial cells (CEC and mature cells called progenitors called CEP) or circulating tumor cells (CTC) in adult patients with metastatic cancer, possibly treated with targeted therapy.</brief_summary>
	<brief_title>Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Second Primary</mesh_term>
	<mesh_term>Neoplastic Cells, Circulating</mesh_term>
	<criteria>Patients with metastatic solid tumor Age&gt; 18 years Signed consent Patients with diseases associated with vascular lesions known. Patients protected by law, in accordance with Articles L11215 to L11218 of the Code of Public Health. Mental pathology that can interfere with the proper conduct of the study. Refusal of consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Patients</keyword>
</DOC>